Comparison of Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) with Beam and Busulfan/Melphalan (Bu/Mel) in Concurrent Cohorts of Refractory Hodgkin'S Lymphoma (HL) Patients Receiving an Autologous Stem-Cell Transplant

✍ Scribed by Y. Nieto; R.B. Jones; P. Liu; P. Anderlini; U. Popat; B. Andersson; E.J. Shpall; A. Alousi; C. Hosing; P. Kebriaei; M. Qazilbash; E. Frazier; C. Chancoco; Q. Bashir; S. Ciurea; S. Parmar; R. Champlin

• Book ID: 116282852
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 93 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.013